Location: Leuven
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Leuven
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Long-term Longitudinal Imaging of Presynaptic Terminals in PD NA · UZ Leuven · Universitaire Ziekenhuizen KU Leuven · NCT06875765 A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) Phase 3 · Universitair Ziekenhuis Leuven · Janssen Research & Development, LLC · NCT06449651 Observational Study Protocol: LIVER-R Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis Phase 2 · Investigational Site Number : 0560001 · Sanofi · NCT06867094 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W Phase 3 · UZ Leuven · Pfizer · NCT07028853 Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Phase 3 · UZ Leuven - Centrum voor Moleculaire en Vasculaire Biologie · CSL Behring · NCT07080905 Performance After Cardiac Ablation in Endurance Athletes for Atrial Fibrillation NA · UZ Leuven · University Hospital of Leuven Leuven · NCT07726056 A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma Phase 2/Phase 3 · UZ Leuven · University of Birmingham · NCT05991388 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia Phase 3 · UZ Leuven · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line Phase 3 · UZ Leuven-Hematology ( Site 0200) · Merck Sharp & Dohme LLC · NCT06136559 A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis Phase 2 · UZ Leuven · Boehringer Ingelheim · NCT06636656 Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY) Phase 3 · Katholieke Universiteit te Leuven · NTC srl · NCT07465705 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients Phase 2 · Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg · Miltenyi Biomedicine GmbH · NCT04844866 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease Phase 3 · Site BE32003 · Astellas Pharma Global Development, Inc. · NCT05970172 Pilot Study on Muscle, Tendon, and Neural Changes Post-Botulinum Toxin Injections in Post-stroke Spastic Equinovarus NA · Uz Leuven · Universitaire Ziekenhuizen KU Leuven · NCT06767631 A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr Phase 2 · Universitair Ziekenhuis Leuven /ID# 277350 · AbbVie · NCT06682988 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P Phase 2 · UZ Leuven · Pfizer · NCT07073820 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease Phase 2 · UZ Leuven · Boehringer Ingelheim · NCT07355296 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease Phase 3 · Investigational Site Number : 0560001 · Sanofi · NCT07190196 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop Phase 3 · UZ Leuven Gasthuisberg · Hoffmann-La Roche · NCT06793215 Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies Phase 3 · Universitair Ziekenhuis Leuven · Lakefront Biotherapeutics NV · NCT06652633 Conservative Endometrioma Surgery NA · UZLeuven · Universitaire Ziekenhuizen KU Leuven · NCT04151433 The Oxford Risk Factors And Non-Invasive Imaging Study Phase N/A · University Hospitals Leuven · University of Oxford · NCT05169333 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Universitair Ziekenhuis Leuven - Campus Gasthuisberg · Amgen · NCT07037433 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease Phase 2 · UZ Leuven · Eli Lilly and Company · NCT07483099 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena Phase 3 · UZ Leuven ( Site 0401) · Merck Sharp & Dohme LLC · NCT07216703 A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pou Phase 3 · UZ Leuven · Takeda · NCT06443502 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Phase N/A · UZ Leuven · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele NA · UZ Leuven Gasthuisberg · Alimentiv Inc. · NCT07363044
Look up another city
Look up another condition